Boston University resists claims COVID strain

Ghano Dzpro
18 Oct, 2022

Boston University resists claims of new 'killer' COVID strain

Monday reports had said the school's National Emerging Infectious Disease Laboratories had created a new, more lethal version of the virus.


Boston University resists claims of new killer COVID strain
new killer COVID strain


There is some friction between the federal government and Boston University researchers after a new study on COVID-19 was published.


Poe said reports from some publications that it has created a new "fatal" strain of COVID are misleading and incorrect.


In a statement: "First, this research is not gain-of-function research, which means it did not amplify the Washington State SARS-COV-2 virus strain (the original virus from 2020) or make it more dangerous." Monday's reports are "false and inaccurate." BU said in a statement


"Indeed, this research made virus replication less dangerous," the university said.



The National University Laboratories for Emerging Infectious Diseases were studying the omicron variant and the original strain. They reportedly wanted to see if omicron, while highly contagious, was still less likely to cause severe illness.

The researchers were working with this hybrid virus where they took the serrated protein from an omicron and linked it to the original strain.

In mice, they found that this new, molten version killed 80% of infected mice. But this is less than the 100% that died due to the original bloodline. So their conclusion is that it is not the omicron spiked protein itself that causes the virus to spread easily but the other proteins.

Boston University researchers say identifying these proteins will help better diagnose and treat COVID-19.

The study caught the National Institute of Allergy and Infectious Diseases, which helps fund Boston University research, by surprise. But the university said the research was reviewed and approved by the Institutional Biosafety Committee, which is made up of scientists and members of the local community, and that the Boston Public Health Commission also approved the research.

Ultimately, this research will provide a public benefit, by leading to better, targeted therapeutic interventions to help combat future epidemics, according to the university's statement.


Ghano Dzpro

Ghano Dzpro

Ghano Dzpro is the founder of this Blog. It's the creative mind behind KLWP themes and KWGT widgets and Pinterest content, as well as the editor. Ghano Dzpro mostly covers mobile and app content, as he has experience in these topics.

Next Post Previous Post
No Comment
Add Comment
comment url